カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の婦人科用プロゲスチン薬物市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Gynecological Progestin Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19367）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19367
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：105
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の婦人科用プロゲスチン薬物市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

婦人科用プロゲスチン薬物市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の婦人科用プロゲスチン薬物の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

婦人科用プロゲスチン薬物市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・プロゲステロン、ジドロゲステロン、その他

用途別セグメントは次のように区分されます。
・病院調剤薬局、小売調剤薬局、オンライン調剤薬局

世界の婦人科用プロゲスチン薬物市場の主要な市場プレーヤーは以下のとおりです。
・Merck、Teva Generics、Besins Healthcare、Virtus Pharmaceuticals, LLC、BionPharma、Aquatic Remedies、Zhejiang Xianju Pharmaceutical、Zhejiang Aisheng Pharmaceutical、Zhejiang Medicine、Hubei Dongxin Pharmaceutical、Tianjin Jinyao Pharmaceutical、Guangzhou Baiyunshan Mingxing Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、婦人科用プロゲスチン薬物製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な婦人科用プロゲスチン薬物メーカーの企業概要、2019年～2022年までの婦人科用プロゲスチン薬物の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な婦人科用プロゲスチン薬物メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別婦人科用プロゲスチン薬物の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの婦人科用プロゲスチン薬物の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での婦人科用プロゲスチン薬物市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および婦人科用プロゲスチン薬物の産業チェーンを掲載しています。
・第13、14、15章では、婦人科用プロゲスチン薬物の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 婦人科用プロゲスチン薬物の概要
- 種類別分析（2017年vs2021年vs2028年）：プロゲステロン、ジドロゲステロン、その他
- 用途別分析（2017年vs2021年vs2028年）：病院調剤薬局、小売調剤薬局、オンライン調剤薬局
- 世界の婦人科用プロゲスチン薬物市場規模・予測
- 世界の婦人科用プロゲスチン薬物生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Merck、Teva Generics、Besins Healthcare、Virtus Pharmaceuticals, LLC、BionPharma、Aquatic Remedies、Zhejiang Xianju Pharmaceutical、Zhejiang Aisheng Pharmaceutical、Zhejiang Medicine、Hubei Dongxin Pharmaceutical、Tianjin Jinyao Pharmaceutical、Guangzhou Baiyunshan Mingxing Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：プロゲステロン、ジドロゲステロン、その他
・用途別分析2017年-2028年：病院調剤薬局、小売調剤薬局、オンライン調剤薬局
・婦人科用プロゲスチン薬物の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・婦人科用プロゲスチン薬物のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・婦人科用プロゲスチン薬物のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・婦人科用プロゲスチン薬物の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・婦人科用プロゲスチン薬物の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Gynecological Progestin Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gynecological Progestin Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital Pharmacies accounting for % of the Gynecological Progestin Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Progesterone segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gynecological Progestin Drugs include Merck, Teva Generics, Besins Healthcare, Virtus Pharmaceuticals, LLC, and BionPharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gynecological Progestin Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Progesterone
Dydrogesterone
Others
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Gynecological Progestin Drugs market are listed below:
Merck
Teva Generics
Besins Healthcare
Virtus Pharmaceuticals, LLC
BionPharma
Aquatic Remedies
Zhejiang Xianju Pharmaceutical
Zhejiang Aisheng Pharmaceutical
Zhejiang Medicine
Hubei Dongxin Pharmaceutical
Tianjin Jinyao Pharmaceutical
Guangzhou Baiyunshan Mingxing Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gynecological Progestin Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gynecological Progestin Drugs, with price, sales, revenue and global market share of Gynecological Progestin Drugs from 2019 to 2022.
Chapter 3, the Gynecological Progestin Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gynecological Progestin Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gynecological Progestin Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gynecological Progestin Drugs.
Chapter 13, 14, and 15, to describe Gynecological Progestin Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Gynecological Progestin Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gynecological Progestin Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Progesterone
1.2.3 Dydrogesterone
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Gynecological Progestin Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Gynecological Progestin Drugs Market Size & Forecast
1.4.1 Global Gynecological Progestin Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gynecological Progestin Drugs Sales in Volume (2017-2028)
1.4.3 Global Gynecological Progestin Drugs Price (2017-2028)
1.5 Global Gynecological Progestin Drugs Production Capacity Analysis
1.5.1 Global Gynecological Progestin Drugs Total Production Capacity (2017-2028)
1.5.2 Global Gynecological Progestin Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gynecological Progestin Drugs Market Drivers
1.6.2 Gynecological Progestin Drugs Market Restraints
1.6.3 Gynecological Progestin Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Gynecological Progestin Drugs Product and Services
2.1.4 Merck Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva Generics
2.2.1 Teva Generics Details
2.2.2 Teva Generics Major Business
2.2.3 Teva Generics Gynecological Progestin Drugs Product and Services
2.2.4 Teva Generics Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Besins Healthcare
2.3.1 Besins Healthcare Details
2.3.2 Besins Healthcare Major Business
2.3.3 Besins Healthcare Gynecological Progestin Drugs Product and Services
2.3.4 Besins Healthcare Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Virtus Pharmaceuticals, LLC
2.4.1 Virtus Pharmaceuticals, LLC Details
2.4.2 Virtus Pharmaceuticals, LLC Major Business
2.4.3 Virtus Pharmaceuticals, LLC Gynecological Progestin Drugs Product and Services
2.4.4 Virtus Pharmaceuticals, LLC Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BionPharma
2.5.1 BionPharma Details
2.5.2 BionPharma Major Business
2.5.3 BionPharma Gynecological Progestin Drugs Product and Services
2.5.4 BionPharma Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Aquatic Remedies
2.6.1 Aquatic Remedies Details
2.6.2 Aquatic Remedies Major Business
2.6.3 Aquatic Remedies Gynecological Progestin Drugs Product and Services
2.6.4 Aquatic Remedies Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Zhejiang Xianju Pharmaceutical
2.7.1 Zhejiang Xianju Pharmaceutical Details
2.7.2 Zhejiang Xianju Pharmaceutical Major Business
2.7.3 Zhejiang Xianju Pharmaceutical Gynecological Progestin Drugs Product and Services
2.7.4 Zhejiang Xianju Pharmaceutical Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Zhejiang Aisheng Pharmaceutical
2.8.1 Zhejiang Aisheng Pharmaceutical Details
2.8.2 Zhejiang Aisheng Pharmaceutical Major Business
2.8.3 Zhejiang Aisheng Pharmaceutical Gynecological Progestin Drugs Product and Services
2.8.4 Zhejiang Aisheng Pharmaceutical Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Zhejiang Medicine
2.9.1 Zhejiang Medicine Details
2.9.2 Zhejiang Medicine Major Business
2.9.3 Zhejiang Medicine Gynecological Progestin Drugs Product and Services
2.9.4 Zhejiang Medicine Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Hubei Dongxin Pharmaceutical
2.10.1 Hubei Dongxin Pharmaceutical Details
2.10.2 Hubei Dongxin Pharmaceutical Major Business
2.10.3 Hubei Dongxin Pharmaceutical Gynecological Progestin Drugs Product and Services
2.10.4 Hubei Dongxin Pharmaceutical Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Tianjin Jinyao Pharmaceutical
2.11.1 Tianjin Jinyao Pharmaceutical Details
2.11.2 Tianjin Jinyao Pharmaceutical Major Business
2.11.3 Tianjin Jinyao Pharmaceutical Gynecological Progestin Drugs Product and Services
2.11.4 Tianjin Jinyao Pharmaceutical Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Guangzhou Baiyunshan Mingxing Pharmaceutical
2.12.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Details
2.12.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Major Business
2.12.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Gynecological Progestin Drugs Product and Services
2.12.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Gynecological Progestin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gynecological Progestin Drugs Breakdown Data by Manufacturer
3.1 Global Gynecological Progestin Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gynecological Progestin Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gynecological Progestin Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Gynecological Progestin Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Gynecological Progestin Drugs Manufacturer Market Share in 2021
3.5 Global Gynecological Progestin Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gynecological Progestin Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gynecological Progestin Drugs Market Size by Region
4.1.1 Global Gynecological Progestin Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Gynecological Progestin Drugs Revenue by Region (2017-2028)
4.2 North America Gynecological Progestin Drugs Revenue (2017-2028)
4.3 Europe Gynecological Progestin Drugs Revenue (2017-2028)
4.4 Asia-Pacific Gynecological Progestin Drugs Revenue (2017-2028)
4.5 South America Gynecological Progestin Drugs Revenue (2017-2028)
4.6 Middle East and Africa Gynecological Progestin Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gynecological Progestin Drugs Sales in Volume by Type (2017-2028)
5.2 Global Gynecological Progestin Drugs Revenue by Type (2017-2028)
5.3 Global Gynecological Progestin Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gynecological Progestin Drugs Sales in Volume by Application (2017-2028)
6.2 Global Gynecological Progestin Drugs Revenue by Application (2017-2028)
6.3 Global Gynecological Progestin Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gynecological Progestin Drugs Sales by Type (2017-2028)
7.2 North America Gynecological Progestin Drugs Sales by Application (2017-2028)
7.3 North America Gynecological Progestin Drugs Market Size by Country
7.3.1 North America Gynecological Progestin Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Gynecological Progestin Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gynecological Progestin Drugs Sales by Type (2017-2028)
8.2 Europe Gynecological Progestin Drugs Sales by Application (2017-2028)
8.3 Europe Gynecological Progestin Drugs Market Size by Country
8.3.1 Europe Gynecological Progestin Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Gynecological Progestin Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gynecological Progestin Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Gynecological Progestin Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Gynecological Progestin Drugs Market Size by Region
9.3.1 Asia-Pacific Gynecological Progestin Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gynecological Progestin Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gynecological Progestin Drugs Sales by Type (2017-2028)
10.2 South America Gynecological Progestin Drugs Sales by Application (2017-2028)
10.3 South America Gynecological Progestin Drugs Market Size by Country
10.3.1 South America Gynecological Progestin Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Gynecological Progestin Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gynecological Progestin Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Gynecological Progestin Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Gynecological Progestin Drugs Market Size by Country
11.3.1 Middle East & Africa Gynecological Progestin Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gynecological Progestin Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gynecological Progestin Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gynecological Progestin Drugs
12.3 Gynecological Progestin Drugs Production Process
12.4 Gynecological Progestin Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gynecological Progestin Drugs Typical Distributors
13.3 Gynecological Progestin Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Gynecological Progestin Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gynecological Progestin Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Gynecological Progestin Drugs Product and Services
Table 6. Merck Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Teva Generics Basic Information, Manufacturing Base and Competitors
Table 8. Teva Generics Major Business
Table 9. Teva Generics Gynecological Progestin Drugs Product and Services
Table 10. Teva Generics Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Besins Healthcare Basic Information, Manufacturing Base and Competitors
Table 12. Besins Healthcare Major Business
Table 13. Besins Healthcare Gynecological Progestin Drugs Product and Services
Table 14. Besins Healthcare Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Virtus Pharmaceuticals, LLC Basic Information, Manufacturing Base and Competitors
Table 16. Virtus Pharmaceuticals, LLC Major Business
Table 17. Virtus Pharmaceuticals, LLC Gynecological Progestin Drugs Product and Services
Table 18. Virtus Pharmaceuticals, LLC Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. BionPharma Basic Information, Manufacturing Base and Competitors
Table 20. BionPharma Major Business
Table 21. BionPharma Gynecological Progestin Drugs Product and Services
Table 22. BionPharma Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Aquatic Remedies Basic Information, Manufacturing Base and Competitors
Table 24. Aquatic Remedies Major Business
Table 25. Aquatic Remedies Gynecological Progestin Drugs Product and Services
Table 26. Aquatic Remedies Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Zhejiang Xianju Pharmaceutical Major Business
Table 29. Zhejiang Xianju Pharmaceutical Gynecological Progestin Drugs Product and Services
Table 30. Zhejiang Xianju Pharmaceutical Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Zhejiang Aisheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Zhejiang Aisheng Pharmaceutical Major Business
Table 33. Zhejiang Aisheng Pharmaceutical Gynecological Progestin Drugs Product and Services
Table 34. Zhejiang Aisheng Pharmaceutical Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors
Table 36. Zhejiang Medicine Major Business
Table 37. Zhejiang Medicine Gynecological Progestin Drugs Product and Services
Table 38. Zhejiang Medicine Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Hubei Dongxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Hubei Dongxin Pharmaceutical Major Business
Table 41. Hubei Dongxin Pharmaceutical Gynecological Progestin Drugs Product and Services
Table 42. Hubei Dongxin Pharmaceutical Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Tianjin Jinyao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Tianjin Jinyao Pharmaceutical Major Business
Table 45. Tianjin Jinyao Pharmaceutical Gynecological Progestin Drugs Product and Services
Table 46. Tianjin Jinyao Pharmaceutical Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Guangzhou Baiyunshan Mingxing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Guangzhou Baiyunshan Mingxing Pharmaceutical Major Business
Table 49. Guangzhou Baiyunshan Mingxing Pharmaceutical Gynecological Progestin Drugs Product and Services
Table 50. Guangzhou Baiyunshan Mingxing Pharmaceutical Gynecological Progestin Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Gynecological Progestin Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Gynecological Progestin Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Gynecological Progestin Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Gynecological Progestin Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Gynecological Progestin Drugs Production Site of Key Manufacturer
Table 56. Gynecological Progestin Drugs New Entrant and Capacity Expansion Plans
Table 57. Gynecological Progestin Drugs Mergers & Acquisitions in the Past Five Years
Table 58. Global Gynecological Progestin Drugs Sales by Region (2017-2022) & (K Units)
Table 59. Global Gynecological Progestin Drugs Sales by Region (2023-2028) & (K Units)
Table 60. Global Gynecological Progestin Drugs Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Gynecological Progestin Drugs Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Gynecological Progestin Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Global Gynecological Progestin Drugs Sales by Type (2023-2028) & (K Units)
Table 64. Global Gynecological Progestin Drugs Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Gynecological Progestin Drugs Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Gynecological Progestin Drugs Price by Type (2017-2022) & (US$/Unit)
Table 67. Global Gynecological Progestin Drugs Price by Type (2023-2028) & (US$/Unit)
Table 68. Global Gynecological Progestin Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Global Gynecological Progestin Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Global Gynecological Progestin Drugs Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Gynecological Progestin Drugs Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Gynecological Progestin Drugs Price by Application (2017-2022) & (US$/Unit)
Table 73. Global Gynecological Progestin Drugs Price by Application (2023-2028) & (US$/Unit)
Table 74. North America Gynecological Progestin Drugs Sales by Country (2017-2022) & (K Units)
Table 75. North America Gynecological Progestin Drugs Sales by Country (2023-2028) & (K Units)
Table 76. North America Gynecological Progestin Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Gynecological Progestin Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Gynecological Progestin Drugs Sales by Type (2017-2022) & (K Units)
Table 79. North America Gynecological Progestin Drugs Sales by Type (2023-2028) & (K Units)
Table 80. North America Gynecological Progestin Drugs Sales by Application (2017-2022) & (K Units)
Table 81. North America Gynecological Progestin Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Europe Gynecological Progestin Drugs Sales by Country (2017-2022) & (K Units)
Table 83. Europe Gynecological Progestin Drugs Sales by Country (2023-2028) & (K Units)
Table 84. Europe Gynecological Progestin Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Gynecological Progestin Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Gynecological Progestin Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Europe Gynecological Progestin Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Europe Gynecological Progestin Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Europe Gynecological Progestin Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Gynecological Progestin Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Gynecological Progestin Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Gynecological Progestin Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Gynecological Progestin Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Gynecological Progestin Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Gynecological Progestin Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Gynecological Progestin Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Gynecological Progestin Drugs Sales by Application (2023-2028) & (K Units)
Table 98. South America Gynecological Progestin Drugs Sales by Country (2017-2022) & (K Units)
Table 99. South America Gynecological Progestin Drugs Sales by Country (2023-2028) & (K Units)
Table 100. South America Gynecological Progestin Drugs Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Gynecological Progestin Drugs Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Gynecological Progestin Drugs Sales by Type (2017-2022) & (K Units)
Table 103. South America Gynecological Progestin Drugs Sales by Type (2023-2028) & (K Units)
Table 104. South America Gynecological Progestin Drugs Sales by Application (2017-2022) & (K Units)
Table 105. South America Gynecological Progestin Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Gynecological Progestin Drugs Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Gynecological Progestin Drugs Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Gynecological Progestin Drugs Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Gynecological Progestin Drugs Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Gynecological Progestin Drugs Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Gynecological Progestin Drugs Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Gynecological Progestin Drugs Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Gynecological Progestin Drugs Sales by Application (2023-2028) & (K Units)
Table 114. Gynecological Progestin Drugs Raw Material
Table 115. Key Manufacturers of Gynecological Progestin Drugs Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Gynecological Progestin Drugs Typical Distributors
Table 119. Gynecological Progestin Drugs Typical Customers
List of Figures
Figure 1. Gynecological Progestin Drugs Picture
Figure 2. Global Gynecological Progestin Drugs Revenue Market Share by Type in 2021
Figure 3. Progesterone
Figure 4. Dydrogesterone
Figure 5. Others
Figure 6. Global Gynecological Progestin Drugs Revenue Market Share by Application in 2021
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Global Gynecological Progestin Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Gynecological Progestin Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Gynecological Progestin Drugs Sales (2017-2028) & (K Units)
Figure 13. Global Gynecological Progestin Drugs Price (2017-2028) & (US$/Unit)
Figure 14. Global Gynecological Progestin Drugs Production Capacity (2017-2028) & (K Units)
Figure 15. Global Gynecological Progestin Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Gynecological Progestin Drugs Market Drivers
Figure 17. Gynecological Progestin Drugs Market Restraints
Figure 18. Gynecological Progestin Drugs Market Trends
Figure 19. Global Gynecological Progestin Drugs Sales Market Share by Manufacturer in 2021
Figure 20. Global Gynecological Progestin Drugs Revenue Market Share by Manufacturer in 2021
Figure 21. Gynecological Progestin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Gynecological Progestin Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Gynecological Progestin Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Gynecological Progestin Drugs Sales Market Share by Region (2017-2028)
Figure 25. Global Gynecological Progestin Drugs Revenue Market Share by Region (2017-2028)
Figure 26. North America Gynecological Progestin Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Europe Gynecological Progestin Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Gynecological Progestin Drugs Revenue (2017-2028) & (USD Million)
Figure 29. South America Gynecological Progestin Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Gynecological Progestin Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Global Gynecological Progestin Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Gynecological Progestin Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Gynecological Progestin Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Gynecological Progestin Drugs Sales Market Share by Application (2017-2028)
Figure 35. Global Gynecological Progestin Drugs Revenue Market Share by Application (2017-2028)
Figure 36. Global Gynecological Progestin Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Gynecological Progestin Drugs Sales Market Share by Type (2017-2028)
Figure 38. North America Gynecological Progestin Drugs Sales Market Share by Application (2017-2028)
Figure 39. North America Gynecological Progestin Drugs Sales Market Share by Country (2017-2028)
Figure 40. North America Gynecological Progestin Drugs Revenue Market Share by Country (2017-2028)
Figure 41. United States Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Gynecological Progestin Drugs Sales Market Share by Type (2017-2028)
Figure 45. Europe Gynecological Progestin Drugs Sales Market Share by Application (2017-2028)
Figure 46. Europe Gynecological Progestin Drugs Sales Market Share by Country (2017-2028)
Figure 47. Europe Gynecological Progestin Drugs Revenue Market Share by Country (2017-2028)
Figure 48. Germany Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Gynecological Progestin Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Gynecological Progestin Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Gynecological Progestin Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Gynecological Progestin Drugs Revenue Market Share by Region (2017-2028)
Figure 57. China Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Gynecological Progestin Drugs Sales Market Share by Type (2017-2028)
Figure 64. South America Gynecological Progestin Drugs Sales Market Share by Application (2017-2028)
Figure 65. South America Gynecological Progestin Drugs Sales Market Share by Country (2017-2028)
Figure 66. South America Gynecological Progestin Drugs Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Gynecological Progestin Drugs Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Gynecological Progestin Drugs Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Gynecological Progestin Drugs Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Gynecological Progestin Drugs Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Gynecological Progestin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Gynecological Progestin Drugs in 2021
Figure 78. Manufacturing Process Analysis of Gynecological Progestin Drugs
Figure 79. Gynecological Progestin Drugs Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のプロゲステロン薬物市場2022年：市場規模予測（～2028年）
  • プロゲステロン薬のグローバル市場展望 2023年-2029年：カプセル、錠剤、その他
  • 世界の精神薬＆神経薬市場2022年：市場規模予測（～2028年）
  • 世界の婦人科検査用電動椅子市場2022年：市場規模予測（～2028年）
  • サルタン系医薬品におけるAPIの世界市場2023年：ロサルタンAPI、バルサルタンAPI、イルベサルタンAPI、オルメサルタンAPI、カンデサルタンAPI、テルミサルタンAPI
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19367 )"世界の婦人科用プロゲスチン薬物市場2022年：市場規模予測（～2028年）" (英文：Global Gynecological Progestin Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。